Profile:
Section 3(1) of the National Drug Policy and Authority Act Cap 206 established National Drug Authority (NDA) as a body corporate with perpetual succession and a common seal, and may sue or be sued in its corporate name.

NDA Board:
The Act refers to the Board of NDA as the Authority. It is composed of the Chairperson and 19 members from various government organizations, professions and prominent persons. The Board conducts its work through the following expert Committees.

Committee on National Formulary
The Committee is charged with the responsibility of registering medicines in the country after evaluating information submitted on it by the Secretariat. The Committee is also responsible for deregistering medicines that become un-fit for human consumption.
Committee on Pharmacovigilance and Clinical Trials
The Committee is responsible for monitoring effects of medicines on human and animals.
Committee on Medical Devices and Equipments
The Committee is charged with evaluating all medical devices and equipments (including condoms, gloves, syringes, etc…) by specifying the requirements that must be complied with before they are allowed into the country.
Committee on Veterinary Medicines
The Committee addresses issues relating to veterinary medicines.
Committee on Traditional and Herbal Medicines
The Committee is responsible for setting standards, advancement and use of traditional and herbal medicines.
Audit Committee.
The Committee ensures that NDA funds are utilized in accordance with financial regulations governing NDA and government institutions.
Human Resource Committee
The Committee is responsible for recruitment, training and retention of employees.
Legal Committee
The Committee handles all legal matters which NDA may be faced with. 

NDA Secretariat
The Secretariat is headed by the Executive Secretary/Registrar. It is responsible for the day-to-day activities of the Authority. The secretariat is responsible for the implementation of the objectives of the National Drug Policy and Authority Act. It implements the mandate of the Authority through the functions of Drug Assessment and Registration, Inspectorate Services, Drug Quality Control and Drug Information/ Pharmacovigilance. In doing so, NDA performs several functions mandated by Section 5 of the Act:

• Deal with the development and regulation of the pharmacies and drugs in the country.

• Approve the national list of essential drugs and supervise the revisions of the list in a manner provided by the Minister.

• Estimate drug needs to ensure that the needs are met as economically as possible. 

• Control the importation, exportation and sale of pharmaceuticals

• Control the quality of drugs.

• Promote and control local production of essential drugs.

• Encourage research and development of herbal medicines.

• Promote rational use of drugs through appropriate professional training.

• Establish and revise professional guidelines and disseminate information to the health professionals and the public.

• Provide advice and guidance to the Minister and bodies concerned with drugs on the implementation of the national drug policy and

• Perform any other function that is connected with the above or that may be accorded to it by law.